SCHEMBL4924786

SCHEMBL4924786

Cc1cc(COc2c(Br)cc(CC(F)C(=O)O)cc2Br)cc(NCC2CC2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 8/20 0.39
THRB P10828 8/20 0.39
FFAR1 O14842 2/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TACR1 P25103 1/20 0.33
CRHR1 P34998 1/20 0.33
DHODH Q02127 2/20 0.32
POLB P06746 1/20 0.32
ITGB3 P05106 3/20 0.32
ITGB1 P05556 3/20 0.32
ITGAV P06756 3/20 0.32
ITGA2B P08514 3/20 0.32
ITGA5 P08648 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5718046 0.95 THRA (0.36) THRATHRBFFAR1MEN1KMT2A
SCHEMBL4931110 0.90 CRHR1 (0.36) FFAR1TACR1CRHR1ITGB3ITGB1
SCHEMBL4932962 0.89 THRA (0.38) THRATHRBFFAR1CRHR1DHODH
SCHEMBL5718049 0.87 MAPT (0.34) THRATHRBMEN1KMT2AKDM4E
SCHEMBL5717905 0.87 FFAR1 (0.36) FFAR1MEN1KMT2ALMNAMAPT
SCHEMBL4922928 0.87 THRB (0.50) THRATHRBFFAR1LMNAMAPT
SCHEMBL4932126 0.87 THRA (0.42) THRATHRBTACR1CRHR1
SCHEMBL4931744 0.86 THRB (0.42) THRATHRBFFAR1MEN1KMT2A
SCHEMBL4926936 0.84 THRB (0.43) THRATHRBFFAR1SMN1; SMN2
SCHEMBL4933385 0.84 MEN1 (0.39) THRATHRBFFAR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA THRA 3/4885THRB 4/4885FFAR1 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.